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In most areas of medicine there are large variations in 
practice; the management of peripheral vascular dis- 
ease is no exception. For example, the patient with 
intermittent claudication may be told to "stop smok- 
ing and keep walking"; prescribed vasoactive drugs; 
enrolled in a supervised exercise programme; offered 
percutaneous angioplasty or even arterial reconstruc- 
tion. Many questions also surround the diagnosis and 
management of abdominal aortic aneurysms. Is pop- 
ulation screening effective in reducing death from 
aortic rupture? Should small aneurysms be repaired or 
simply observed? Regardless of how vehemently 
experts argue their point of view, the answers to these 
questions are, in truth, unknown; and will remain so 
until randomised controlled trials (RCT), such as the 
Medical Research Council (MRC) U.K. Small Aneu- 
rysm Trial, are completed. 1 Thus, it was not until the 
results of the European Carotid Surgery Trial (ECST) 
and the North American Symptomatic Carotid Endar- 
terectomy Trial (NASCET) became available, that after 
30 years of controversN consensus amongst surgeons 
and neurologists was finally reached with regard to 
the place of carotid endarterectomy in the treatment of 
carotid artery stenosis. 2'3 
Although many factors affect practice, it is the 
individual opinion, some would say prejudice, of the 
clinician that most clearly determines the treatment 
received, or not received, by any particular patient. 
Unfortunately, this may result in decisions being taken 
on the basis of information that is at best anecdotal 
and, at worst, in conflict with the known facts. For 
example, many children may have died of measles 
because the benefit of antibiotics, although proven, 
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was not widely recognised. 4 Thousands of premature 
babies may have perished unnecessarily because the 
benefits of corticosteroid therapy were not realised 
until a systematic review was published in 1989. s
The blame for this predicament cannot be placed 
solely at the feet of the individual clinicians. The sheer 
volume of medical literature, as well as the biased way 
in which it is presented, makes it impossible for any 
one person to discover and analyse all the available 
evidence. A comprehensive, and comprehensible, sci- 
entific database of high quality information on which 
treatment can be based is a very rare commodity. 
Often the necessary RCTs have not been done; 
sometimes the trials may have been done but the 
conclusions lost from view; and sometimes the trials 
have not been published. Even when medical reviews 
of RCT are published, the scientific methods used 
evaluate the known information are often sub- 
standard. 
The urgent need to improve the situation is glar- 
ingly obvious on medical, moral, financial, and polit- 
ical grounds. As the cost of health care spirals 
upwards, value for money becomes a key issue~ 
Purchasers, whether they be health authorities, budget 
holding general practitioners, insurance companies, or 
individual patients need and demand to know that the 
services with which they are provided are reasonable, 
appropriate and based upon scientifically robust 
data. 
Archie Cochrane was an Oxford based epidemiolo- 
gist who pointed out that, because health resources 
would always be limited, they should be used 
equitably to provide those treatments, and only those 
treatments, that have been shown to be effective. In 
1979 he wrote, "it is surely a great criticism of our 
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profession that we have not organised a critical 
summary by speciality or subspecialit)~ adapted peri- 
odically, of all relevant randomised controlled trials".6 
The Cochrane Collaboration has taken up the 
challenge. 
The International Cochrane Collaboration was born 
in 1992 and now has well over 1000 members. The 
Collaboration aims to create a register of completed 
and continuing RCTs; to combine the results of trials 
that meet set standards of quality; to produce reg- 
ularly updated systematic reviews or meta-analyses; 
and to make this information widely available 
through modern media format such as CD-ROM and 
the internet. 7 Despite the existence of sophisticated 
computerised databases this means hand-searching of 
journals; scouring registers of trials and other "grey 
literature" such as conference proceedings and theses; 
and interrogation of foreign language databases. 
The first systematic reviews to be included in the 
Cochrane Collaboration were in the field of pregnancy 
and childbirth and have had considerable influence on 
obstetric and paediatric practice throughout the 
world. 5 Since then there has been increased interest 
from professional groups, health managers, and gov- 
ernment organisations in extending the scope of 
systematic reviews. Cochrane centres have now been 
established in eight countries world-wide, and are 
funded by government and charitable sources. The 
Peripheral Vascular Disease Review Group of the 
Cochrane Collaboration was inaugurated on 1st Jan- 
uary 1995 and has as its editorial base the University 
of Edinburgh; although it should be noted that four 
different countries are represented by the four current 
Editors. The Group has as its remit a wide range of 
both venous and arterial disorders. Members of the 
Group have already expressed interest in taking 
responsibility for thrombo-embolism, venous ulcers, 
varicose veins, atherosclerotic disease of the lower 
limb, abdominal aortic aneurysm, and vasospastic 
disorders. It is worth mentioning that literature 
pertaining to carotid artery disease is already being 
searched by the Stroke Review Group. 
Funding and personnel are two major obstacles to 
achieving the aims of the Review Group. In respect of 
the former the Group has recently received a grant for 
secretarial, administrative and day-to-day running 
costs from the Chief Scientist Office of the Scottish 
Office. With respect o the latter, any individual who 
feels that they would like to join to the Review Group 
is invited to write to Ruth Jepson, Administrator, 
Cochrane Review Group on Peripheral Vascular Dis- 
eases, Department of Public Health Sciences, Medical 
School Teviot Place, Edinburgh EH8 9AG Scotland 
(Fax 0131-650-6904, Telephone 0131-650-3206). 
It is regrettable that the average patient has little 
protection from the doctor who closes his or her mind 
to the scientific evidence. However, we can at least 
help to ensure that ignorance based on the non- 
availability of that evidence is not a reason or an 
excuse for inappropriate health care. s-~° 
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